Cited by 280Cancer survivorship and careOvarian cancer diagnosis and treatmentChildhood Cancer Survivors' Quality of Life

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the functional assessment of cancer therapy-ovarian

Basen-Engquist, Karen, Bodurka-Bevers, Diane, Fitzgerald, Mary A., Webster, Kimberly, Cella, David, Hu, Shaohua, Gershenson, David M.·2001·Journal of Clinical Oncology

DOI 10.1200/jco.2001.19.6.1809

Open this paper in CoChat — free account

Abstract

PURPOSE: To report the reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) in a consecutive series of outpatients with epithelial ovarian cancer. PATIENTS AND METHODS: Two hundred thirty-two ovarian cancer patients attending an outpatient gynecologic oncology clinic completed questionnaires at baseline. The patients' FACT-O scores were compared with their performance status, disease stage, treatment status, and other factors hypothesized to be related to quality of life. Patients received a second questionnaire either one week after baseline to assess the instrument's test-retest reliability and/or two months after baseline to evaluate its sensitivity to change in performance status. RESULTS: Internal consistency and test-retest reliability of the FACT-O were adequate. Overall, the scales correlated with other measures as expected; all correlations were in the hypothesized direction. Patients with advanced disease, poor performance status, and who were receiving active treatment had lower scores on physical, functional, and ovarian cancer-specific scales. The total FACT-O and emotional well-being scores were lower for patients with poor performance status and patients in active treatment. The FACT-O total and all subscale scores except emotional well-being were sensitive to decreases in performance status. CONCLUSION: Overall, the FACT-O provides a reliable and valid assessment of the quality of life of women with ovarian cancer, and is appropriate as a brief quality of life assessment in clinical trials and descriptive studies.

Integrity signals

Registry

Crossref · 10.1200/jco.2001.19.6.1809

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Applied Multivariate Statistics for the Social Sciences
Stevens, J. P. (2012) · Routledge eBooks · doi:10.4324/9780203843130 · Cited by 10,652
A new scale of social desirability independent of psychopathology.
Crowne, D. P., & Marlowe, D. (1960) · Journal of Consulting Psychology · doi:10.1037/h0047358 · Cited by 8,686
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citation
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00274-6 · Cited by 1,964
Self-citation
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.974 · Cited by 1,752
Self-citation
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., Sobel, K., Coyle, N., Kemeny, N. E., Norton, L., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90182-1 · Cited by 1,580
Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.472 · Cited by 1,052
Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
Zubrod, C. G., Schneiderman, M. A., Frei, E., Brindley, C. O., Gold, G. L., Shnider, B. I., Oviedo, R., Gorman, J. G., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E. J., & Bonomi, P. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00450-f · Cited by 750
Self-citation

Flagged first, then by citations

Show all 28 references

1 of the 28 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–277 of 277

Physical and functional well-being and symptoms of ovarian cancer in women undergoing first-line of chemotherapy: a one-year follow-up
Ferracini, A. C., Pereira, G., de Souza, C. M., dos Santos, T. F. C., Sarian, L. O., Derchain, S., & Mazzola, P. G. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06298-3 · Cited by 5
Quality of Life in Patients with Ovarian Cancer
Jensen, S. E., & Cella, D. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8271-0_14 · Cited by 5
Self-citation
Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial
Kvale, E. A., Phillips, F., Ghosh, S., Lea, J. S., Hoppenot, C. M. V., Costales, A. B., Sunde, J. S., Badr, H., Nwogu-Onyemkpa, E., Saleem, N., et al. (2023) · JMIR Research Protocols · doi:10.2196/48069 · Cited by 4
Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study
Mlakar, I., Lin, S. M., Nateqi, J., Gruarin, S., Diéguez, L., Piairo, P., Pires, L. R., Tement, S., Aleksandraviča, I., Leja, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11072041 · Cited by 5
Right Place, Right Time: Preferences of Women with Ovarian Cancer for Delivery of CAM Education
Ebbert, J., Donovan, K. A., Lengacher, C. A., Fabri, D., Reich, R. R., Daley, E. M., Thompson, E. L., & Wenham, R. M. (2015) · Medicines · doi:10.3390/medicines2030236 · Cited by 4
Propriedades psicométricas de dois instrumentos para avaliação da qualidade de vida relacionada à saúde em mulheres com câncer de colo de útero
Fregnani, C. M. S. (2013) · doi:10.11606/t.22.2013.tde-23052014-124457 · Cited by 4
Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors
Pennington, K. P., Schlumbrecht, M., McGregor, B. A., Goodheart, M. J., Heron, L., Zimmerman, B., Telles, R., Zia, S., Penedo, F. J., & Lutgendorf, S. K. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107612 · Cited by 3
Predictors of the 6-min walk test in patients with ovarian cancer
Karataş, A. S. K., Karadibak, D., Gulteki̇n, S. C., Özsoy, İ., Yavuzşen, H. T., Yavuzşen, T., & Öztop, İ. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07706-6 · Cited by 3
Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges
Lefkovits, Y. R., Heriot, N., Sporik, A., Perera, S., Friedlander, M. L., Dixon, C., Cohen, P. A., Lee, Y. C., Hyde, S. E., Richardson, G. E., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11042-8 · Cited by 3
Quality of life assessment in cancer clinical research: current status and a look to the future
Gotay, C. C. (2003) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.3.4.479 · Cited by 3
Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review
Moss, C. L., Urbano, T. G., White, I. M., Taylor, B. P., Kristeleit, R. S., Montes, A., Fox, L., Beyer, K., Sztankay, M. J., Ratti, M. M., et al. (2023) · Future Oncology · doi:10.2217/fon-2022-0111 · Cited by 3
Palliative Care and Quality of Life
Chase, D. M., Wong, S., Wenzel, L. B., & Monk, B. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40067-1.00020-6 · Cited by 3
Evaluation of numerical rating scale and neuropathic pain symptom inventory pain scores in advanced ovarian carcinoma patients undergoing surgery and first-line chemotherapy
Sarkar, S., Pal, R., Mahata, S., Sahoo, P. K., Ghosh, S., Chatterjee, P., Vernekar, M., Mandal, S., Bera, T., & Nasare, V. D. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202201.010 · Cited by 3
Palliative Care Opportunities for Women with Advanced Ovarian Cancer Associated with Intraperitoneal Chemotherapy
Otis‐Green, S., Wakabayashi, M. T., Morgan, R. J., Hakim, A. A., FERRELL, B. R., Sun, V. C.-Y., Yang, E., & GRANT, M. M. (2012) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0174 · Cited by 3
Quality of Life and Sexual Functioning
Bodurka, D. C., & Sun, C. C. (2006) · Springer eBooks · doi:10.1007/0-387-28796-5_16 · Cited by 3
The experience of gynaecological cancer survivors : supportive care needs and use
Beesley, V. L. (2006) · Faculty of Health · Cited by 4
Validity and Reliability of the Turkish Version of National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Ovarian Symptom Index‐18 (NFOSI‐18) and Neurotoxicity‐4 (NTX‐4) for Patients with Advanced Ovarian Cancer
Yavuzşen, H. T., Gulteki̇n, S. C., Polat, K., Keser, M., Güç, Z. G., Keskinkilic, M., Yavuzşen, T., & Karadibak, D. (2023) · European Journal of Cancer Care · doi:10.1155/2023/5521892 · Cited by 2
Sleep characteristics and recurrence in platinum-sensitive ovarian cancer survivors: A prospective cohort study
Benoit, M., Sylvestre, M., Datta, G. D., Gilbert, L., Ho, V., Karp, I., Lacaille, J., Lau, S. K., Samouëlian, V., & Koushik, A. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101540 · Cited by 2
Palliative Care and Quality of Life
Chase, D. M., Wong, S., Wenzel, L. B., & Monk, B. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07419-3.00020-5 · Cited by 2
Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
Lou, Y., Lu, L., Li, Y., Liu, M., Bredle, J. M., & Jia, L. (2015) · Journal of Palliative Medicine · doi:10.1089/jpm.2015.0061 · Cited by 2
Health Economic and Outcomes Research in Cancer
Skrepnek, G. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-24814-1_17 · Cited by 2
Qualidade de vida em mulheres com câncer ginecológico: uma revisão da literatura
Silva, C. H. D., & Derchain, S. (2006) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2006v52n1.1908 · Cited by 2
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
Pappa, C., Galaal, K. A., Smyth, S. L., Bristow, R. E., Khashan, A. S., & Alazzam, M. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015297 · Cited by 2
Étude de la qualité de vie dans les néoplasies ovariennes : outils et enjeux
Bryand, A., Hamidou, Z., Paget‐Bailly, S., Bonnetain, F., Mathelin, C., Baldauf, J., & Akladios, C. Y. (2015) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2014.12.011 · Cited by 2
Quality of Life in the Gynecologic Cancer Patient
Bodurka, D. C., Sun, C. C., & Basen-Engquist, K. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-443-07142-3.50063-4 · Cited by 2
Self-citation
Quality of Life in Women with Ovarian Cancer
Campbell, R., King, M. T., Lee, Y. C., Mileshkin, L., Tait, M.-A., & Rutherford, C. (2022) · Springer eBooks · doi:10.1007/978-3-031-09169-8_13 · Cited by 1
Psychosocial considerations in head and neck cancer
Shinn, E. H., & Chopra, D. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11806-7.00016-3 · Cited by 1
Quality of life and survivorship in patients with low-grade ovarian cancer
Lemieux, M., Telles, R., Goodheart, M. J., Dahmoush, L., Hagemann, I. S., Penedo, F. J., Nandakumar, R., Cole, S. W., Sood, A. K., Lutgendorf, S. K., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.08.010 · Cited by 1
Feasibility of a mobile health platform for patient education and remote symptom monitoring in patients with advanced ovarian cancer undergoing primary chemotherapy
Smith, H. J., Dinkins, K. G., Liang, M. I., Chu, D. I., & Huh, W. K. (2026) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.12.006 · Cited by 1
PROMs: Patient related or patient centred? A bridge between Patient-Reported Outcome Measures (PROMs) and clinical ethics in the context of a cohort of gynaeco-oncological patients analysed by qualitative semi- structured interviews
Theis, S., Frühwein, H., Hasenburg, A., Moehler, M., & Paul, N. W. (2026) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-026-01050-z · Cited by 1
Multidisciplinary management of advanced ovarian cancer in Spain: expert recommendations for achieving maximum survival and improving patient care
Barretina-Ginesta, M.-P., Madariaga, A., Barahona, M., Gallego, A., Guerra-Alía, E. M., Matías‐Guiu, X., Sánchez‐Heras, A. B., Casla-Barrio, S., Castaño, F., Concepción, M. G., et al. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04467-6 · Cited by 1
Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials
Lorusso, D., Mainenti, S., Ferrandina, G., & Scambia, G. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.57 · Cited by 1
Qualitative analysis of gynecologic oncology patients’ experience with treatment holidays
Margolis, B., Sutter, M. E., Boyd, L. R., & Winkel, A. F. (2021) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2021.100911 · Cited by 1
Quality of Life
Siembida, E. J., & Salsman, J. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-85702-8_24 · Cited by 1
Quality of Life
Salsman, J. M., Pearman, T. P., & Cella, D. F. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4866-2_15 · Cited by 1
Self-citation
Patient reported outcomes (PROs): Considerations for implementation in your ERAS program
Huepenbecker, S. P., & Meyer, L. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91208-2.00002-0 · Cited by 1
Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol
Hayes, S. C., Spence, R. R., Janda, M., Eakin, E., Shannon, C., Goh, J. C. H., Beesley, V. L., Vagenas, D., Webb, P. M., Coward, J. I. G., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077158 · Cited by 1
Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer
Uyar, D. S., Michener, C. M., Bishop, E. A., Hopp, E. E., Simpson, P. M., Zhang, L., Rader, J. S., Rose, P. G., Mahdi, H., Debernardo, R. L., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1291090 · Cited by 1
Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery
Falla-Zúñiga, L. F., Sardi, A., King, M. C., Nikiforchin, A., Lopez‐Ramirez, F., Barakat, P., Nieroda, C. A., Gushchin, V., & Diaz-Montes, T. P. (2024) · Surgical Oncology Insight · doi:10.1016/j.soi.2024.100073 · Cited by 1
Health-Related Quality of Life and Patient-Reported Outcomes
Hess, L. M. (2010) · Springer eBooks · doi:10.1007/978-3-642-12130-2_11 · Cited by 1
Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis
Crawford, B., Piault, Gotlieb, & Joulain (2012) · Patient Related Outcome Measures · doi:10.2147/prom.s28179 · Cited by 1
Validação e reprodutibilidade de dois questionários específicos para avaliar qualidade de vida de pacientes com câncer de ovário
Schroeter, D. (2011) · doi:10.11606/d.6.2011.tde-28092011-163407 · Cited by 1
An exercise intervention for women undergoing chemotherapy for ovarian cancer : feasibility and preliminary outcomes
Newton, M. J. (2010) · Cited by 1
Quality of Life of Patients with Ovarian Cancer
Chie, W., & Greimel, E. (2012) · InTech eBooks · doi:10.5772/27298
Physical Activity and Gynaecologic Cancer in Nova Scotia
Tyrrell, A. (2013) · Library and Archives Canada (Government of Canada)
Weekly Dose-dense Paclitaxel and Carboplatin in Recurrent Ovarian Cancer—A Phase II Trial
Tawfik, H. A., Shawky, H., & Hewidy, M. (2014) · Brachytherapy · doi:10.1016/j.brachy.2014.08.032
Health and Support Needs of Women Living with Gynaecologic Cancer
Walton, L. S. (2011) · ResearchSpace (University of Auckland)
Qualidade de vida em mulheres com câncer ginecológico: uma revisão da literatura Quality Of Life In Women With Gynecologic Cancer: a literature review
Henrique, C., Françoise, S., & Derchain, M. (2006)
AD, COMUNICA CIÓN Y EMOCIONE S: ESTUDIO SITUACIO NAL CON MUJERES AFECTADA S DE CÁNCER GINECOLÓ GICO
Lluch, J. R. G., & Valero, S. (2010)
eHealth and the burden of cancer survivorship.
Cox, A. (2016) · Surrey Research Insight Open Access (The University of Surrey)
Health-Related Quality of Life in Women with Gynaecological Cancer
Leung, J. (2019) · Queensland University of Technology · doi:10.5204/thesis.eprints.130759
Quality Surveys to Compare Chemotherapy-induced Toxicity and Quality of Life between Two Paclitaxel and Carboplatin Regimens for Ovarian Carcinoma
Kim, M. K. (2019) · Medical Case Reports Journal · doi:10.31531/2581-5563.1000116
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study
Wenzel, L. B., Huang, H. Q., Cella, D. F., McKinney, C. O., Zevon, M. A., Lachance, J. A., Walker, J. L., Salani, R., Modesitt, S. C., Morris, R. T., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.08.028
Self-citation
Cancer-related fatigue: the role of demographic and medical factors, symptom severity, illness perceptions, and coping strategies in testing Leventhal’s Common Sense Model in ovarian cancer patients
Hare, C. J. (2021) · doi:10.32920/ryerson.14644332.v1
Outcomes Research
Litwin, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00005-0
Effects of adult attachment on health outcomes among couples facing ovarian cancer and the mediating role of dyadic coping
Crangle, C. J. (2021) · doi:10.32920/ryerson.14649156.v1 · Cited by 1
Symptom Burden and Quality of Life With Chemotherapy for Recurrent Ovarian Cancer: The Gynecologic Cancer InterGroup-Symptom Benefit Study
Lee, Y. C., King, M. T., O’Connell, R. L., Lanceley, A., Joly, F., Hilpert, F., Davis, A. J., Roncolato, F. T., Okamoto, A., Bryce, J., et al. (2022) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001075
Palliative care and quality of life
Chase, D. M., Satero, J., Wenzel, L. B., & Monk, B. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77684-4.00028-3
Data from Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer
Westin, S. N., Labrie, M., Litton, J. K., Blucher, A., Fang, Y., Vellano, C. P., Marszalek, J. R., Feng, N., Ma, X., Creason, A., et al. (2023) · doi:10.1158/1078-0432.c.6531402.v1
Avaliação de polimorfismos genéticos e qualidade de vida em mulheres com carcinoma de ovário
Ferracini, A. C. (2021) · doi:10.47749/t/unicamp.2021.1245745
Efficacy of Maintenance Therapy With Adjuvant Chemotherapy of Three Steps in Patients Newly Diagnosed With Advanced Ovarian Cancer: A Phase II Randomised Clinical Trial
Zheng, Z., Wang, H., Yang, H., Tang, J., Xi, C., Zhang, M., Ren, Y., Chen, X., Ju, X., Xu, L., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18178
Additional file 3 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221987
Additional file 5 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221993
Additional file 1 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221981
Additional file 12 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221978
Additional file 10 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221972
Additional file 6 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221996
Additional file 11 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221975
Additional file 8 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20222002
Additional file 4 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221990
Additional file 9 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20222005
Additional file 7 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221999
Additional file 2 of Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
Kennedy, F., Shearsmith, L., Holmes, M., Rogers, Z., Carter, R., Hofmann, U., & Velikova, G. (2022) · Figshare · doi:10.6084/m9.figshare.20221984
Identifying sleep disturbance- and fatigue-related factors of poor health-related quality of life in patients with advanced ovarian cancer
Newell, A., Fortune, E. E., Andaç-Jones, E., Gonzalo, M. B., & Szamreta, E. A. (2026) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-026-01040-1
Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention (‘REVITALIZE’) to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol
Arch, J. J., Uno, H., Poort, H., Slivjak, E. T., Nealis, M. S., Park, H., Wang, I., Genung, S. R., Cronin, A. M., Andorsky, D. J., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-15936-0
Design of the Comprehensive Outcomes for After Cancer Health (COACH) Trial: a randomized, wait-list control digital health coaching intervention for cancer survivors
Fessele, K. L., Loftis, J., Alzahid, S., Arceneaux, B., Armah, J., Arthur, E., Swartz, M. C., Conley, Y., Eche, I. J., Flora, L. K., et al. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108474
Distress in Women with Ovarian Cancer
DellaRipa, J. A. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/gdba-8203

Authors: Basen-Engquist, K., Bodurka-Bevers, D., Fitzgerald, M. A., Webster, K., Cella, D., Hu, S., & Gershenson, D. M.
Affiliations: Northwestern University (US)
From the University of Texas M.D. Anderson Cancer Center, Houston, TX; and Center on Outcomes, Research and Education, Evanston Northwestern Healthcare and Northwestern University, Evanston, IL.
ORCID: Basen-Engquist, Karen
Webster, Kimberly
Cella, David
Hu, Shaohua
Gershenson, David M.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2001-03-15
Volume: 19
Issue: 6
Pages: 1809-1817
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2001.19.6.1809
OpenAlex: W2244770355
Cited by: 280
References: 28
Citations by year: 2026: 6 · 2025: 3 · 2024: 10 · 2023: 17 · 2022: 31 · 2021: 17 · 2020: 4 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 11 · 2015: 11 · 2014: 16 · 2013: 16 · 2012: 14
FWCI: 2.18
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
Keywords: ovarian cancer, quality of life, test-retest reliability, internal consistency, performance status, sensitivity to change, emotional well-being, functional status, instrument validation
MeSH terms: Activities of Daily Living, Adult, Aged, Clinical Trials as Topic, Emotions, Family Health, Female, Health Status, Humans, Middle Aged, Neoplasm Staging, Ovarian Neoplasms, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Social Support, Reproducibility of Results, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the functional assessment of cancer therapy-ovarian

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks